Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and protease

G Haas1, A Samri, E Gomard

  • 1Department of Molecular Biology, Max-Planck-Institut für Infektionsbiologie, Berlin, Germany.

AIDS (London, England)
|September 4, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.

HIV medicine·2024
Same author

Comparison of HIV-Infected and Noninfected Patients Undergoing Bariatric Surgery: The ObeVIH Study.

Journal of acquired immune deficiency syndromes (1999)·2022
Same author

Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up.

Infectious diseases now·2022
Same author

Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.

Infectious diseases now·2021
Same author

Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic.

The British journal of dermatology·2021
Same author

Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study.

Infectious diseases now·2021

Cytotoxic T lymphocyte (CTL) responses targeting HIV-1 pol products are common in patients, with reverse transcriptase (RT) being highly immunogenic. Identifying these CTL epitopes is crucial for immune control and enhancing antiretroviral therapy.

Area of Science:

  • Immunology
  • Virology
  • HIV Research

Background:

  • Cytotoxic T lymphocytes (CTLs) play a critical role in controlling viral infections, including Human Immunodeficiency Virus type 1 (HIV-1).
  • Understanding CTL responses to HIV-1 proteins is essential for developing effective vaccines and immunotherapies.

Purpose of the Study:

  • To identify immunodominant regions and novel epitopes within HIV-1 pol products (reverse transcriptase, integrase, protease) recognized by CTLs.
  • To analyze these CTL responses across different stages of HIV-1 disease progression.

Main Methods:

  • Cross-sectional analysis of 98 HIV-1 patients from the French IMMUNOCO cohort.
  • Assessment of CTL recognition of HIV-1 pol products using recombinant vaccinia virus constructs and synthetic peptides.

Related Experiment Videos

Main Results:

  • Memory CTL responses against HIV-1 pol products were detected in 78% of patients, irrespective of disease stage.
  • Reverse transcriptase (RT) demonstrated higher immunogenicity (81%) compared to integrase (51%) and protease (24%).
  • Two new clusters of antigenic regions and one conserved cluster of epitopes were identified in RT, with specific epitopes mapped to amino acid positions.

Conclusions:

  • Memory CTL responses against HIV-1 pol products are prevalent in most patients, even at advanced disease stages.
  • The identification of immunodominant regions and novel epitopes provides valuable targets for immune-based interventions.
  • The ability of CTLs to recognize multiple epitopes simultaneously may enhance immune control and improve antiretroviral drug efficacy.